Overview: This presentation will focus on the major regulatory issues that concern diagnostic and pharmaceutical partners during co-development of a targeted therapeutic and companion diagnostic including, current development trends related to companion diagnostics, coordination of clinical trials, and the regulatory review of both products in the US and EU.